NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed | PAR 22 205

Opportunity Information: Apply for PAR 22 205

The NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed (Funding Opportunity Number PAR-22-205) is a discretionary grant program offered by the National Institutes of Health (NIH), specifically tied to NIAMS interests, and categorized under the Health funding activity area (CFDA 93.846). It is designed to support clinical research preparation and trial readiness activities rather than the conduct of a clinical trial itself. In practice, this type of R34 opportunity is generally used to help investigators complete the critical planning work needed to launch a future clinical study, such as finalizing protocols, building operational infrastructure, and addressing regulatory and logistical requirements. The key restriction is explicit in the title: clinical trials are not allowed under this award, meaning applicants should not propose enrolling participants into an interventional trial or carrying out trial activities that constitute a clinical trial during the R34 project period.

Eligible applicants span a wide range of U.S.-based organizations and government entities. This includes state, county, and city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. Higher education institutions are eligible across the spectrum, including public and state-controlled institutions of higher education as well as private institutions of higher education. Tribal eligibility includes federally recognized Native American tribal governments and Native American tribal organizations other than federally recognized tribal governments. The announcement also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). Nonprofit organizations are eligible whether or not they hold 501(c)(3) status (as long as they are not institutions of higher education), and both for-profit organizations (other than small businesses) and small businesses are also listed as eligible. Faith-based or community-based organizations and eligible agencies of the federal government may apply as well, along with regional organizations and U.S. territories or possessions.

Foreign participation is handled with a specific set of rules. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined by the NIH Grants Policy Statement, which typically means a U.S. applicant may include certain foreign collaborations or performance sites when well-justified and compliant with NIH policy, even though the primary applicant organization must remain eligible and domestic under the terms of this opportunity.

The funding instrument is a grant, and the listing provides an original closing date of 2023-11-03 and a creation date of 2022-08-10. Some fields such as the award ceiling and expected number of awards are not specified in the provided source data. Overall, the opportunity is best understood as support for structured, milestone-driven planning work that positions a future NIAMS-relevant clinical study for success, while drawing a firm boundary against using R34 funds to run an actual clinical trial during the award period.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
• This funding opportunity was created on 2022-08-10.
• Applicants must submit their applications by 2023-11-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 22 205

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: